Literature DB >> 22080653

A multifaceted intervention strategy for eradication of a hospital-wide outbreak caused by carbapenem-resistant Klebsiella pneumoniae in Southern Israel.

Abraham Borer1, Seada Eskira, Ronit Nativ, Lisa Saidel-Odes, Klaris Riesenberg, Ilana Livshiz-Riven, Francisc Schlaeffer, Michael Sherf, Nejama Peled.   

Abstract

OBJECTIVE: To devise a local strategy for eradication of a hospital-wide outbreak caused by carbapenem-resistant Klebsiella pneumoniae (CRKP).
DESIGN: Quasi-experimental, before-and-after, interrupted time-series study.
SETTING: A 1,000-bed tertiary-care university teaching hospital.
METHODS: Retrospectively, all relevant data were collected from the medical records of patients with CRKP infections from May 2006 through April 2007, the preintervention period. From May 1, 2007, through May 1, 2010, the postintervention period, the intervention was applied and prospectively followed. The 5 key elements of this strategy were an emergency department flagging system, the building of a cohort ward, the eradication of clusters, environmental and personnel hand cultures, and a carbapenem-restriction policy. The demographic and clinical parameters of patients colonized by and/or infected with CRKP were collected from medical records.
RESULTS: A total of 10,680 rectal cultures were performed for 8,376 patients; 433 (5.16%) and 370 (4.4%) were CRKP-colonized and CRKP-infected patients, respectively, and 789 (98%) of 803 patients were admitted to the CRKP cohort ward. The CRKP infection density was reduced from 5.26 to 0.18 per 10,000 patient-days (P ≤ .001), and no nosocomial CRKP infections were diagnosed. Twenty-three percent of environmental cultures were found to be positive. Meropenem use was reduced from 283 ± 70.92 to 118 ± 74.32 defined daily doses per 1,000 patient-days (P ≤ .001).
CONCLUSION: This intervention produced an enormous impact on patient location, surveillance cultures, and antibiotic policies and a massive investment in infection control resources.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22080653     DOI: 10.1086/662620

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  19 in total

1.  Imported Klebsiella pneumoniae carbapenemase-producing K. pneumoniae clones in a Greek hospital: impact of infection control measures for restraining their dissemination.

Authors:  Aggeliki Poulou; Evangelia Voulgari; Georgia Vrioni; Grigorios Xidopoulos; Aris Pliagkos; Vassiliki Chatzipantazi; Fani Markou; Athanassios Tsakris
Journal:  J Clin Microbiol       Date:  2012-05-30       Impact factor: 5.948

2.  Emergence of carbapenem-resistant Enterobacteriaceae in Orange County, California, and support for early regional strategies to limit spread.

Authors:  Shruti K Gohil; Raveena Singh; Justin Chang; Adrijana Gombosev; Tom Tjoa; Matthew Zahn; Patti Steger; Susan S Huang
Journal:  Am J Infect Control       Date:  2017-07-27       Impact factor: 2.918

Review 3.  Carbapenem-Resistant Enterobacteriaceae in Solid Organ Transplantation: Management Principles.

Authors:  Olivia Smibert; Michael J Satlin; Anoma Nellore; Anton Y Peleg
Journal:  Curr Infect Dis Rep       Date:  2019-06-10       Impact factor: 3.725

4.  Prevention and control of intensive care unit-acquired carbapenem-resistant Klebsiella pneumoniae: need for a multimodal approach.

Authors:  Arta Karruli; Roberto Andini; Antonio Corcione; Emanuele Durante-Mangoni
Journal:  Ann Transl Med       Date:  2019-12

5.  A Systematic Review and Meta-analyses of the Clinical Epidemiology of Carbapenem-Resistant Enterobacteriaceae.

Authors:  Karlijn van Loon; Anne F Voor In 't Holt; Margreet C Vos
Journal:  Antimicrob Agents Chemother       Date:  2017-12-21       Impact factor: 5.191

Review 6.  Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases.

Authors:  L Silvia Munoz-Price; Laurent Poirel; Robert A Bonomo; Mitchell J Schwaber; George L Daikos; Martin Cormican; Giuseppe Cornaglia; Javier Garau; Marek Gniadkowski; Mary K Hayden; Karthikeyan Kumarasamy; David M Livermore; Juan J Maya; Patrice Nordmann; Jean B Patel; David L Paterson; Johann Pitout; Maria Virginia Villegas; Hui Wang; Neil Woodford; John P Quinn
Journal:  Lancet Infect Dis       Date:  2013-09       Impact factor: 25.071

Review 7.  Antimicrobial agent exposure and the emergence and spread of resistant microorganisms: issues associated with study design.

Authors:  C Angebault; A Andremont
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-12-27       Impact factor: 3.267

Review 8.  Limiting and controlling carbapenem-resistant Klebsiella pneumoniae.

Authors:  Lisa Saidel-Odes; Abraham Borer
Journal:  Infect Drug Resist       Date:  2013-12-10       Impact factor: 4.003

9.  Deaths attributable to carbapenem-resistant Enterobacteriaceae infections.

Authors:  Matthew E Falagas; Giannoula S Tansarli; Drosos E Karageorgopoulos; Konstantinos Z Vardakas
Journal:  Emerg Infect Dis       Date:  2014-07       Impact factor: 6.883

10.  Efficacy of admission screening for extended-spectrum beta-lactamase producing Enterobacteriaceae.

Authors:  Christopher F Lowe; Kevin Katz; Allison J McGeer; Matthew P Muller
Journal:  PLoS One       Date:  2013-04-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.